Introduction
Chronic graft versus host disease (cGVHD) is the most common late complication of allogeneic stem cell transplantation (alloSCT) (1) . Clinical management of cGVHD depends on immunosuppressive agents to target lymphocytes, but therapy is complicated by untoward side effects, infections and frequent failure to control the underlying process. More than 20% of primary causes of death is cGVHD among patients who are disease free two years after alloSCT (2) . To establish a better therapeutic strategy, it is important to determine the cell types and the mediators that are responsible for cGVHD.
The role of chemokines in acute GVHD (aGVHD) has been actively studied (3) . However, few reports have examined their role in cGVHD (4) (5) (6) .
Fractalkine/CX3CL1 is an unique chemokine that exists not only as a chemo-attracting soluble factor but also as a membrane-anchored form that mediates adhesion of leukocytes expressing its cognitive receptor CX3CR1 to the endothelium (7, 8) .
Monocyte is one of the major cell types which express CX3CR1 (8, 9). The immune responses of fractalkine-deficient mice to a variety of T cell-mediated inflammatory stimuli, such as delayed-type hypersensitivity, were not impaired (10). However, fractalkine-or CX3CR1-deficient mice exhibited reduced atherogenesis due to impaired recruitment of monocytes (11, 12) . The strong expression of fractalkine or predominant infiltration of monocytes has been reported in some chronic autoimmune disorders (13-15). Because autoimmune disorders and cGVHD share many clinical manifestations, we focused on monocytes as a candidate of responsible cell type other than lymphocytes.
We examined their distribution in the blood and skin of cGVHD patients in association with chemokine fractalkine/receptor CX3CR1 axis.
Materials and Methods

Blood and tissue samples
Peripheral blood samples for flow cytometric analyses were obtained from 19 patients who had undergone alloSCT (11 men, 8 women; age: range 20-71, median 41; days after transplantation: range 97-3523, median 681, conditioning: 11 received myeloablative, 8 non-myeloablative regimen, 8 containing total body irradiation (TBI), stem cell source: 11 related peripheral blood stem cell, 5 unrelated bone marrow, 2 related bone marrow, 1 cord blood. The profile of each patient is listed in Supplemental Table 1 ). Skin biopsy specimens were obtained from alloSCT patients (7 with active rash due to aGVHD, 7 with active rash due to cGVHD and 7 without skin cGVHD.
Each group consists of 4 patients who received myeloablative transplantation with TBI and 3 non-myeloablative transplantation with fludarabine containing regimen. The profile of each patient is listed in Supplemental Table 2 ). All patients studied had no evidence of infection. The protocol was approved by the Institutional Review Board of 6 Okayama University and informed consent was obtained from patients.
Clinical assessment
The clinical severity of cGVHD was assessed according to the report of National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in cGVHD (16). The sum of the each score was used as cGVHD score. The severity of cGVHD was categorized in cGVHD(-)~mild, moderate and severe groups as described (16).
Flow cytometry, Immunohistochemistry, Statistics
Methods can be found in supplemental online materials.
Results and Discussion
CX3CR1+ monocytes were decreased in the blood of severe cGVHD patients
As shown in Figure 1A , CD14+ monocytes in patients with no cGVHD symptom displayed high CX3CR1 expression level (range: 52-83%). Non-transplanted normal individuals showed similar level of expression (not shown). We noticed that this expression was low in patients with severe cGVHD ( Figure 1A) . Correlation between percentage of CX3CR1 positive cells in CD14+ fraction and cGVHD severity score is shown in Figure 1B . There was a strong inverse correlation between cGVHD score and CX3CR1 expression (n=19, p<0.01). Although the numbers of monocytes in the blood were similar in each category ( Figure 1C ), the absolute number of CX3CR1 positive monocytes was drastically decreased in patients with severe cGVHD ( Figure 1D ).
Although it is still possible that some minor lymphocyte subsets might show a correlation similar to that observed in monocytes, the analysis of total lymphocytes characterized by low forward and side scatter from same 19 samples did not display such a trend (Supplemental Figure 1) . These data suggest that the reduction of CX3CR1 positive cells in severe cGVHD patients may be specific for monocytes.
Fractalkine expression and monocyte infiltration in GVHD skin tissues
We first examined skin tissues at the sites of normal appearance, pigmentation and active rash from a patient with skin cGVHD (Figure 2A ). Fractalkine was faintly expressed in epidermis at the sites of normal appearance and pigmentation ( Figure 2B ) similar to that in skin from non-transplanted healthy donor (not shown). In contrast, it was strongly expressed in epidermis with hyperplasia in the skin with active rash ( Figure 2B ). Very few CD14+ cells were observed at the sites of normal appearance and pigmentation ( Figure 2B ) as well as in the skin from non-transplanted healthy donor (not shown). In sharp contrast, dramatic infiltration of CD14+ cells was observed within the superficial dermis in active rash ( Figure 2B ). We observed strong epidermal fractalkine expression in all cGVHD samples with some variety of its level. The number of infiltrated CD14+ cells was significantly higher in skin with rash compared to those with normal appearance from transplanted patients ( Figure 2C , n=7, p<0.01). These data suggest that the strong expression of fractalkine and the infiltration of CD14+ cells are not due to the preparative regimen for alloSCT but likely specific phenomenon in active skin cGVHD.
Epidermal fractalkine expression was also observed in aGVHD skin, with a wide variety in its level (from no to relatively strong expression). Remarkably, the fractalkine positive area was greatly wider in cGVHD (Supplemental Figure 2) , which is consistent with the feature that aGVHD does not show epidermal hyperplasia (17) .
Epidermal hyperplasia is due to the hyperproliferation of keratinocytes, known as a main fractalkine producer in the skin (15). The total amount of fractalkine production from epidermis in cGVHD skin may be much higher than that in aGVHD.
During the study of CD14+ cells in cGVHD skin tissues, we noticed that the infiltration of CD14+ cells was strongly observed at the site along the edge of the dermis bordering the epidermis (Figure 2D ), as if these cells were attracted to the epidermis. The number of CD3+ T cells in this specific area showed no difference between acute and chronic GVHD ( Figure 2E ). Interestingly, there was a trend toward higher number of total cells in cGVHD, and the number of CD14+ cells in cGVHD was significantly higher than that in aGVHD skin in this bordering area ( Figure 2E ABC kit (Vector Laboratories) and VIP (Vector Laboratories) were used to visualize the staining. For dual color staining with CD3, samples were then washed twice in PBS, blocked with PBS+5% horse serum, and incubated with mouse anti-human CD3
antibody (Novocastra, Newcastle upon Tyne, UK) or control mouse IgG (Sigma)
followed by biotinylated-horse anti-mouse IgG (Vector Laboratories). ABC kit (Vector Laboratories) and DAB (Vector Laboratories) were used to visualize the staining.
Methylgreen (Vector Laboratories) was used for the counterstain. Stainings with control antibodies were performed in all experiments and showed no significant non-specific staining (not shown). The number of infiltrated CD14+ cells in cGVHD and transplanted normal skin tissues was counted in randomly selected three rectangles (200 x 400 μm) in dermis near epidermis, and was represented by the average ( Figure 2C ).
For the comparison between acute and chronic GVHD, both CD14+ and CD3+ cells in dual color stained-skin tissues were counted on the edge of the dermis bordering the epidermis ( Figure 2D , red dotted line).
Statistics
Spearman's rank correlation coefficient was used to determine the correlations ( Figure 1B and Supplemental Figure 1B) . Mann-Whitney's U-test was used for non-parametric comparison. P<0.05 was considered statistically significant. 
Supplemental Figure legends
